Labiana, autor en LABIANA Group

Labiana adds a new injectable antibiotic to its portfolio with 0 days withdrawal time in milk (dairy cow)

Labiana | 25 March

Labiana, the pharmaceutical laboratory specialized in animal and human health listed on BME Growth, has added Lexylan, a new antibiotic classified as Category C in its prescription guidelines, to its product portfolio.

Labiana expands its human health business and launches a line dedicated to women’s health.

Labiana | 21 March

Labiana, the pharmaceutical laboratory specialized in both animal and human health listed on BME Growth, is expanding its business in the human health sector with the launch of a product line dedicated entirely to the well-being and care of women.

Labiana se posiciona como entidad capacitada para liberar la comercialización de la flor de cannabis con fines terapéuticos

Labiana | 26 September

Labiana, el laboratorio farmacéutico especializado en salud animal y humana cotizado en el BME Growth, se posiciona como laboratorio experto en el análisis de flor del cannabis con fines terapéuticos, lo que permitirá a las compañías que se encargan de su distribución a nivel mundial, su liberación al mercado.

Labiana divests its Serbian subsidiary through a capital increase agreement

Labiana | 26 June

Labiana divests its Serbian subsidiary through a capital increase agreement

Labiana Health participates in the Medcap 2024 forum

Labiana | 31 May

Labiana, el primer laboratorio veterinario español cotizado en Bolsa, ha hecho público su informe de resultados mostrando un incremento en su facturación en 2023

Visita alcaldesa Corbera a Labiana Pharma

La alcaldesa de Corbera de Llobregat visita la fábrica de Labiana para estudiar el futuro desarrollo industrial de la localidad

Labiana | 29 April

La alcaldesa de Corbera de Llobregat, Rosa Boladeras, acompañada de parte de su equipo de Gobierno visitaron durante la mañana del viernes 26 de abril las instalaciones de Labiana Pharmaceuticals.

Labiana aumenta su facturación hasta los 58,5 millones en 2023

Labiana | 27 April

Labiana, el primer laboratorio veterinario español cotizado en Bolsa, ha hecho público su informe de resultados mostrando un incremento en su facturación en 2023

Labiana emphasizes the importance of prevention to avoid the transmission of diseases between pets and humans

Labiana | 11 October

The company responds to this growing need by reinforcing the products offer in companion animals range. Taking into account that

The era of medical cannabis: a huge therapeutic potential within the European Union

Labiana | 2 August

Fran Fernández Campos, PhD in Pharmacy and Director of R&D at Labiana Pharmaceuticals Cannabis, more popularly known as marijuana, has

Labiana exhibits at the XXV Anembe International Congress of Bovine Medicine

Labiana | 12 May

This year Anembe returns with strenght as the reference congress for bovine health specialists.

Author: Labiana